Join the Stiripentol group to help and get support from people like you.
Stiripentol News
Antiseizure Drug Diacomit Now Approved for Children as Young as 6 Months
SAN MATEO, Calif., Sept. 21, 2022 /PRNewswire/ – Biocodex, Inc., a pharmaceutical company and manufacturer of Diacomit® (stiripentol), announced today that the U.S. Food and Drug Administration (...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...
FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. ...